CBIZ Investment Advisory Services LLC Boosts Stock Position in Encompass Health Co. (NYSE:EHC)

CBIZ Investment Advisory Services LLC lifted its position in Encompass Health Co. (NYSE:EHC) by 38.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 455 shares of the company’s stock after buying an additional 127 shares during the quarter. CBIZ Investment Advisory Services LLC’s holdings in Encompass Health were worth $42,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. one8zero8 LLC purchased a new stake in shares of Encompass Health in the 4th quarter valued at $394,000. Globeflex Capital L P raised its holdings in shares of Encompass Health by 305.5% in the 4th quarter. Globeflex Capital L P now owns 42,739 shares of the company’s stock valued at $3,947,000 after buying an additional 32,200 shares during the period. Madison Investment Advisors LLC purchased a new stake in Encompass Health during the 4th quarter worth about $8,118,000. Tredje AP fonden purchased a new stake in Encompass Health during the 4th quarter worth about $1,847,000. Finally, Vestcor Inc increased its holdings in Encompass Health by 5.0% during the 4th quarter. Vestcor Inc now owns 60,775 shares of the company’s stock worth $5,613,000 after purchasing an additional 2,896 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

Encompass Health Stock Up 2.6 %

Shares of NYSE EHC opened at $96.11 on Friday. The stock has a market cap of $9.68 billion, a PE ratio of 21.55, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $74.45 and a 52-week high of $104.55. The business has a 50-day moving average price of $97.35 and a 200 day moving average price of $96.93.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.71%. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. KeyCorp upped their price target on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday, February 10th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.